[New manifestation of a type 2-inflammation in the upper respiratory tract with nasal polyposis under treatment with an asthma biologic].

Autor:	Gander AE; Departement Innere Medizin, Pneumologie/Schlafmedizin, Kantonsspital Graubünden, Chur, Electronic address: anita.gander@ksgr.ch., Leuenberger M; Departement Innere Medizin, Pneumologie/Schlafmedizin, Kantonsspital Graubünden, Chur.; Pneumologie, Spital Davos., Brand Y; HNO-Klinik, Kantonsspital Graubünden, Chur., Latshang TD; Departement Innere Medizin, Pneumologie/Schlafmedizin, Kantonsspital Graubünden, Chur., Rothe T; Departement Innere Medizin, Pneumologie/Schlafmedizin, Kantonsspital Graubünden, Chur.; Pneumologie, Spital Davos.
Jazyk:	němčina
Zdroj:	Praxis [Praxis (Bern 1994)] 2024 May; Vol. 113 (5), pp. 138-141.
DOI:	10.23785/PRAXIS.2024.05.005
Abstrakt:	Introduction: For 7 years we gained experience of how asthma and chronic rhinosinusitis with nasal polyposis respond to biologics. In contrast, it is much less known, how ASA/NSAID intolerance (Widal's disease) behaves under biologicals. We therefore describe the case of a patient with both clinical conditions who reacted with a severe intolerance reaction under perioperative metamizole administration. Competing Interests: Es bestehen keine Interessenkonflikte (© 2024 Aerzteverlag medinfo AG.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu